Semiannual Report to Congress

October 1, 2009 – March 31, 2010
Office of the Inspector General

Drug Enforcement Administration
DEA logo The DEA enforces federal laws and regulations related to the growth, production, or distribution of controlled substances. In addition, the DEA seeks to reduce the supply of and demand for illicit drugs, both domestically and internationally. The DEA has approximately 10,800 employees staffing its 21 division offices in the United States and the Caribbean and 87 offices in 63 other countries.


During this reporting period, the OIG received 184 complaints involving DEA personnel. The most common allegations made against DEA employees included job performance failure; theft or loss of seized property, money, or drugs; waste; and mismanagement. The OIG opened 8 investigations. The majority of the complaints were considered management issues and were provided to the DEA for its review and appropriate action.

At the close of the reporting period, the OIG had 24 open cases of alleged misconduct against DEA employees. The most common allegations were release of information, false statements, and job performance failure. The following are examples of cases involving the DEA that the OIG’s Investigations Division handled during this reporting period:

Ongoing Work

The DEA’s El Paso Intelligence Center

The OIG is reviewing how the DEA’s El Paso Intelligence Center provides intelligence support to federal, state, and local law enforcement agencies.

The DEA’s Clandestine Drug Laboratory Cleanup Program

The OIG is evaluating the DEA’s Clandestine Laboratory Cleanup Program.

The DEA’s Mobile Enforcement Teams

The OIG is assessing the DEA’s design, implementation, and effectiveness of the Mobile Enforcement Teams (MET) program. The DEA deploys MET teams to assist state, local, and tribal law enforcement in an effort to disrupt or dismantle violent drug trafficking organizations and gangs.


« Previous Table of Contents Next »